FREE Articles - Most Cited articles from 2004–2005

Marzolini C., Paus E., Buclin T., et al.
Polymorphisms in human MDR1 (P-glycoprotein): Recent advances and clinical relevance
Clin Pharmacol Ther. 75, 13-33 (2004).
http://www.cptjournal.org/article/PIIS0009923603003011/fulltext

Mwinyi J., Johne A., Bauer S., et al.
Evidence for inverse effects of OATP-C (SLC21A6) *5 and *1b haplotypes on pravastatin kinetics
Clin Pharmacol Ther. 75, 415-421 (2004).
http://www.cptjournal.org/article/PIIS0009923604000116/fulltext

Kirchheiner J., Brockmoller J.
Clinical consequences of cytochrome P450 2C9 polymorphisms
Clin Pharmacol Ther. 77, 1-16 (2005).
http://www.cptjournal.org/article/PIIS0009923604002772/fulltext

Sparreboom A., Gelderblom H., Marsh S., et al.
Diflomotecan pharmacokinetics in relation to ABCG2 421C > A genotype
Clin Pharmacol Ther. 76, 38-44 (2004).
http://www.cptjournal.org/article/PIIS0009923604000931/fulltext

Sai K., Saeki M., Saito Y., et al.
UGT1A1 haplotypes associated with reduced glucuronidation and increased serum bilirubin in irinotecan-administered Japanese patients with cancer
Clin Pharmacol Ther. 75, 501-515 (2004).
http://www.cptjournal.org/article/PIIS0009923604000359/fulltext